Autopsy report · NCT05460871

Pregabalin for Central Sensitization in TKA

“Enrollment lower than anticipated; none of the subjects completing the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 11 months before it stopped.
• 20 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Iowa

Sponsor type

University, hospital or other

Conditions

Osteo Arthritis Knee; Central Nervous System Sensitization

Interventions

Pregabalin 75mg

Participants

20

Sites

1

Countries

United States

Trials that died the same way

• Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
  “Study did not begin, and no participants were enrolled.” (84% match in meaning)
• Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
  “Enrollment did not progress as anticipated. No participants enrolled.” (83% match in meaning)
• Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
  “The study was not initiated and no participants were enrolled.” (83% match in meaning)
• Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
  “Study was not initiated. No subjects were screened or enrolled.” (81% match in meaning)
• Vaccine Response With NT-I7
  “No subjects enrolled.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.